Regeneron Pharmaceuticals Market Sentiment

Regeneron Pharmaceuticals Inc

REGNNASDAQ

Trade with Public

$805.02

-14.07-1.72%

最終更新: Oct 23, 4:49 PM

概要ニュース業績予想イベント目標株価財務センチメント株主構成配当比較オプション株式レポート

決算: Q3 2026 Q3 2026のこれから金 10 30thの6 日後決算、マーケットオープン前。

決算説明会: 6 日後8:30 午前に電話会議が予定されています。

クリックしてウェブキャストを見る

Regeneron Pharmaceuticals Market Sentiment - Benzinga

Regeneron Pharmaceuticals Market Sentiment

Market sentiment signals for Regeneron Pharmaceuticals (REGN): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 2.2% short float

Options Flow▼ 3.73 P/C ratio

Insider Activity— Neutral (30d)

Analyst Consensus

Buy

29 analysts

Options Flow (P/C)

3.73

More puts — Bearish

181 calls · 675 puts

Avg Consensus PT

$826

+2.7%

Highest Price Target

$1030

+28.1%

Guggenheim

Lowest Price Target

$185

-77.0%

Benchmark

Short Interest

2.2%

Declining — Bullish

Insider Activity (30d)

Neutral

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 21, 2026	TD Cowen	Tyler Van Buren—	+21.9%	$960 → $980	Maintained	Buy
Oct 19, 2026	Piper Sandler	Biren Amin—	+7.6%	$854 → $865	Maintained	Overweight
Oct 15, 2026	UBS	Trung Huynh—	+21.6%	$660 → $978	Upgrade	Neutral→Buy
Oct 8, 2026	RBC Capital	Brian Abrahams—	+0.7%	$737 → $810	Maintained	Sector Perform
Oct 7, 2026	Truist Securities	Gregory Renza—	-3.0%	$772 → $780	Maintained	Buy
Oct 7, 2026	Morgan Stanley	Matthew Harrison—	-3.1%	$758 → $779	Maintained	Equal-Weight
Oct 6, 2026	JP Morgan	Chris Schott—	+18.2%	$900 → $950	Maintained	Overweight
Oct 1, 2026	Jefferies	Akash Tewari—	+15.7%	$870 → $930	Maintained	Buy
Oct 1, 2026	Argus Research	Jasper Hellweg—	+5.7%	$850	Upgrade	Hold→Buy
Sep 29, 2026	RBC Capital	Brian Abrahams—	-8.3%	$737 → $737	Maintained	Sector Perform
Sep 10, 2026	HSBC	Rajesh Kumar—	+14.4%	$800 → $920	Maintained	Buy
Aug 17, 2026	Leerink Partners	David Risinger—	+2.5%	$641 → $824	Maintained	Market Perform
Aug 3, 2026	Citigroup	Geoff Meacham—	-8.0%	$700 → $740	Maintained	Neutral
Aug 3, 2026	Guggenheim	Brad Canino—	+28.1%	$1000 → $1030	Maintained	Buy
Jul 31, 2026	RBC Capital	Brian Abrahams—	-8.3%	$696 → $737	Maintained	Sector Perform
Jul 31, 2026	Morgan Stanley	Matthew Harrison—	-5.7%	$730 → $758	Maintained	Equal-Weight
Jul 31, 2026	Cantor Fitzgerald	Carter Gould—	-1.1%	$750 → $795	Maintained	Overweight
Jul 31, 2026	Wells Fargo	Mohit Bansal—	-6.7%	$700 → $750	Maintained	Equal-Weight
Jul 31, 2026	Truist Securities	Gregory Renza—	-4.0%	$769 → $772	Maintained	Buy
Jul 21, 2026	Guggenheim	Brad Canino—	+24.4%	$995 → $1000	Maintained	Buy
Jul 9, 2026	Piper Sandler	Biren Amin—	+6.2%	$855 → $854	Maintained	Overweight
Jul 8, 2026	Morgan Stanley	Matthew Harrison—	-9.2%	$788 → $730	Maintained	Equal-Weight
Jul 7, 2026	RBC Capital	Brian Abrahams—	-13.4%	$707 → $696	Maintained	Sector Perform
Jul 7, 2026	Truist Securities	Gregory Renza—	-4.4%	$778 → $769	Maintained	Buy
Jul 7, 2026	Benchmark	Robert Wasserman—	-77.0%	$185	Upgrade	Hold→Buy